Hims & Hers launches GLP-1 drug shortage tracker
Hims & Hers (HIMS) has launched an online GLP-1 supply tracker where people can share information about where the popular ...
Hims & Hers launches GLP-1 tracker in response to FDA's shortage decision
Hims & Hers is launching a tracker of GLP-1 shortages to push back against the FDA's recent moves to end compounding copycats ...
After Another Blowout Quarter of Surging Revenue, Is Hims & Hers Stock a Once-in-a-Decade Buy?
Hims & Hers once again delivered a blowout quarter with surging revenue. Revenue soared 77% year over year to $401.6 million, ...
Fierce Healthcare3d
Health tech Q3 earnings recap—Hims & Hers, Doximity, Waystar
Waystar upped its 2024 outlook and now expects total revenue to range between $926 million and $934 million, compared to ...
Hims & Hers launching GLP-1 tracker, Yahoo Finance reports
In response to the FDA’s shortage decision, Hims & Hers is launching a new GLP-1 tracker, allowing patients to self-identify, provide ...
What's Going On With Hims & Hers Health Stock On Wednesday?
Hims & Hers Health launched a GLP-1 Supply Tracker to spotlight challenges in accessing obesity medications, addressing ...
The Motley Fool11d
After Another Blowout Quarter of Surging Revenue, Is Hims & Hers Stock a Once-in-a-Decade Buy?
Even without the contribution from GLP-1 drugs, revenue growth would have soared. The stock is cheap given the company's revenue growth and margins. Hims & Hers strong performance involves much ...
AOL6d
Hims & Hers launches GLP-1 tracker in response to FDA's shortage decision
Hims & Hers (HIMS) is launching a new GLP-1 tracker in its efforts to fight back against the FDA’s decision to end compounded GLP-1s on the market. The tracker allows patients to self-identify ...
Hims & Hers launches GLP-1 shortage tracker in its battle with the FDA
Hims & Hers (HIMS) is launching a new GLP-1 tracker in its efforts to fight back against the FDA’s decision to end compounded ...